BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Merus N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:35 am Sale |
2023-12-31 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 2,752,420 4.800% |
-226,000 (-7.59%) |
Filing |
| 2023-02-14 12:03 pm Sale |
2022-12-31 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 2,978,420 6.400% |
-1,156,651 (-27.97%) |
Filing |
| 2022-02-11 7:22 pm Sale |
2021-12-31 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 4,135,071 9.600% |
-925,000 (-18.28%) |
Filing |
| 2021-07-07 4:35 pm Sale |
2021-07-02 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 5,060,071 13.200% |
-745,500 (-12.84%) |
Filing |
| 2021-02-12 4:16 pm Purchase |
2020-12-31 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 5,805,571 19.960% |
815,000 (+16.33%) |
Filing |
| 2020-06-03 5:03 pm Purchase |
2020-06-01 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 4,990,571 17.200% |
1,820,917 (+57.45%) |
Filing |